|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-1-31
|
|
pubmed:abstractText |
The IGCCCG classification has identified three prognostic groups of patients with metastatic germ-cell tumors. 'Poor prognosis' is based on primary tumor localization, the presence of visceral metastases, and/or high tumor-marker levels. The overall survival rate of these patients is about 45%-55%. The present analysis attempts to identify subsets of patients with a more or less favorable outcome among the 'poor-prognosis' group.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1115-20
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11061604-Adolescent,
pubmed-meshheading:11061604-Adult,
pubmed-meshheading:11061604-Chorionic Gonadotropin,
pubmed-meshheading:11061604-Disease-Free Survival,
pubmed-meshheading:11061604-Female,
pubmed-meshheading:11061604-Germinoma,
pubmed-meshheading:11061604-Humans,
pubmed-meshheading:11061604-L-Lactate Dehydrogenase,
pubmed-meshheading:11061604-Lung Neoplasms,
pubmed-meshheading:11061604-Male,
pubmed-meshheading:11061604-Mediastinal Neoplasms,
pubmed-meshheading:11061604-Middle Aged,
pubmed-meshheading:11061604-Neoplasm Staging,
pubmed-meshheading:11061604-Prognosis,
pubmed-meshheading:11061604-Retroperitoneal Neoplasms,
pubmed-meshheading:11061604-Retrospective Studies,
pubmed-meshheading:11061604-Risk Factors,
pubmed-meshheading:11061604-Survival Rate,
pubmed-meshheading:11061604-Testicular Neoplasms,
pubmed-meshheading:11061604-alpha-Fetoproteins
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
|
|
pubmed:affiliation |
Department of Hematology/Oncology, University of Tübingen Medical Center, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
